Respiratory assessment in centronuclear myopathies
暂无分享,去创建一个
[1] L. F. Black,et al. Maximal static respiratory pressures in generalized neuromuscular disease. , 2015 .
[2] V. Forin,et al. Respiratory muscle decline in duchenne muscular dystrophy , 2014, Pediatric pulmonology.
[3] R. Grange,et al. Gene Therapy Prolongs Survival and Restores Function in Murine and Canine Models of Myotubular Myopathy , 2014, Science Translational Medicine.
[4] J. Pépin,et al. Long-Term Mechanical Ventilation Equipment for Neuromuscular Patients: Meeting the Expectations of Patients and Prescribers , 2014, Respiratory Care.
[5] V. Forin,et al. Longitudinal course of lung function and respiratory muscle strength in spinal muscular atrophy type 2 and 3. , 2013, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[6] Jennifer L. Hefner,et al. Ventilator-dependent children and the health services system. Unmet needs and coordination of care. , 2013, Annals of the American Thoracic Society.
[7] Nasim Vasli,et al. Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy , 2013, Neurology.
[8] M. Tarnopolsky,et al. Genotype-phenotype correlations in recessive RYR1-related myopathies , 2013, Orphanet Journal of Rare Diseases.
[9] E. Malfatti,et al. An Integrated Diagnosis Strategy for Congenital Myopathies , 2013, PloS one.
[10] C. Ottenheijm,et al. P.9.10 Deleting exon 55 from the nebulin gene induces severe muscle weakness in a mouse model for nemaline myopathy , 2013, Neuromuscular Disorders.
[11] J. Weis,et al. Altered Splicing of the BIN1 Muscle-Specific Exon in Humans and Dogs with Highly Progressive Centronuclear Myopathy , 2013, PLoS genetics.
[12] T. Conlon,et al. Phase I/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomes. , 2013, Human gene therapy.
[13] R. Grange,et al. Selenoprotein N deficiency in mice is associated with abnormal lung development , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] J. Bach,et al. Changing Trends in the Management of End-Stage Neuromuscular Respiratory Muscle Failure: Recommendations of an International Consensus , 2013, American journal of physical medicine & rehabilitation.
[15] E. Bertini,et al. Centronuclear myopathy related to dynamin 2 mutations: Clinical, morphological, muscle imaging and genetic features of an Italian cohort , 2013, Neuromuscular Disorders.
[16] G. Nixon,et al. Paediatric home ventilatory support: Changing milieu, proactive solutions , 2013, Journal of paediatrics and child health.
[17] R. Matran,et al. Sniff nasal inspiratory pressure in the longitudinal assessment of young Duchenne muscular dystrophy children , 2012, European Respiratory Journal.
[18] Daniela Stefanut Ti,et al. Sniff Nasal Inspiratory Pressure , 2012 .
[19] R. Grange,et al. Muscle function in A canine model of X‐linked myotubular myopathy , 2012, Muscle & nerve.
[20] M. Resende,et al. Lung function monitoring in patients with duchenne muscular dystrophy on steroid therapy , 2012, BMC Research Notes.
[21] A. Simonds,et al. British Thoracic Society guideline for respiratory management of children with neuromuscular weakness , 2012, Thorax.
[22] K. North,et al. Sniff nasal inspiratory pressure and sleep disordered breathing in childhood neuromuscular disorders , 2012, Neuromuscular Disorders.
[23] K. Bushby,et al. Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene‐associated myopathies , 2012, Human mutation.
[24] B. Fauroux,et al. Interfaces for long-term noninvasive positive pressure ventilation in children , 2012, Intensive Care Medicine.
[25] J. Dowling,et al. Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype. , 2012, Human molecular genetics.
[26] M. Childers,et al. Establishing clinical end points of respiratory function in large animals for clinical translation. , 2012, Physical medicine and rehabilitation clinics of North America.
[27] F. Lofaso,et al. Nocturnal hypoxaemia and hypercapnia in children with neuromuscular disorders , 2011, European Respiratory Journal.
[28] J. Dowling,et al. Prevalence of congenital myopathies in a representative pediatric united states population , 2011, Annals of neurology.
[29] M. Brotto,et al. Disrupted Membrane Structure and Intracellular Ca2+ Signaling in Adult Skeletal Muscle with Acute Knockdown of Bin1 , 2011, PloS one.
[30] J. Bach,et al. Indicators for ventilator use in Duchenne muscular dystrophy. , 2011, Respiratory medicine.
[31] P. Tissières,et al. Inspiratory muscle training in a child with nemaline myopathy and organ transplantation , 2010 .
[32] Sabin R. Bista,et al. Practice parameters for the respiratory indications for polysomnography in children. , 2011, Sleep.
[33] V. Kirk,et al. Executive summary of respiratory indications for polysomnography in children: an evidence-based review. , 2011, Sleep.
[34] A. Spadari,et al. Frequency of the Allelic Variant of the PTPLA Gene Responsible for Centronuclear Myopathy in Labrador Retriever Dogs as Assessed in Italy , 2011, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.
[35] J. Lainé,et al. A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice. , 2010, Human molecular genetics.
[36] Jocelyn Laporte,et al. Case report of intrafamilial variability in autosomal recessive centronuclear myopathy associated to a novel BIN1 stop mutation , 2010, Orphanet journal of rare diseases.
[37] B. Tseng,et al. Consensus Statement on Standard of Care for Congenital Muscular Dystrophies , 2010, Journal of child neurology.
[38] Straub,et al. RYR1 mutations are a common cause of congenital myopathies with central nuclei , 2010, Annals of neurology.
[39] W. Phipatanakul,et al. Clinically Useful Spirometry in Preschool-Aged Children: Evaluation of the 2007 American Thoracic Society Guidelines , 2010, The Journal of asthma : official journal of the Association for the Care of Asthma.
[40] B. Banwell,et al. Nocturnal hypoventilation: predictors and outcomes in childhood progressive neuromuscular disease , 2010, Archives of Disease in Childhood.
[41] L. Kunkel,et al. MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers , 2010, Proceedings of the National Academy of Sciences.
[42] J. Bach,et al. The respiratory management of patients with duchenne muscular dystrophy: A DMD care considerations working group specialty article , 2010, Pediatric pulmonology.
[43] N. Romero. Centronuclear myopathies: A widening concept , 2010, Neuromuscular Disorders.
[44] K. Flanigan,et al. Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy , 2010, Neuromuscular Disorders.
[45] Chien-Wen Chen,et al. Involuntary cough strength and extubation outcomes for patients in an ICU. , 2010, Chest.
[46] H. Panitch. Diurnal hypercapnia in patients with neuromuscular disease. , 2010, Paediatric respiratory reviews.
[47] Julian L Allen. Pulmonary complications of neuromuscular disease: a respiratory mechanics perspective. , 2010, Paediatric respiratory reviews.
[48] T. Conlon,et al. Gel-mediated delivery of AAV1 vectors corrects ventilatory function in Pompe mice with established disease. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[49] K. Claeys,et al. PHENOTYPE OF A PATIENT WITH RECESSIVE CENTRONUCLEAR MYOPATHY AND A NOVEL BIN1 MUTATION , 2010, Neurology.
[50] F. Muntoni,et al. Centronuclear myopathy with cataracts due to a novel dynamin 2 (DNM2) mutation , 2010, Neuromuscular Disorders.
[51] J. Seidman,et al. Ca2+ dysregulation in Ryr1I4895T/wt mice causes congenital myopathy with progressive formation of minicores, cores, and nemaline rods , 2009, Proceedings of the National Academy of Sciences.
[52] L. Boitano. Equipment Options for Cough Augmentation, Ventilation, and Noninvasive Interfaces in Neuromuscular Respiratory Management , 2009, Pediatrics.
[53] M. Sharma,et al. Congenital myopathies – a comprehensive update of recent advancements , 2009, Acta neurologica Scandinavica.
[54] J. Benditt,et al. The American College of Chest Physicians Consensus Statement on the Respiratory and Related Management of Patients With Duchenne Muscular Dystrophy Undergoing Anesthesia or Sedation* , 2009, Pediatrics.
[55] A. Clément,et al. Which tests may predict the need for noninvasive ventilation in children with neuromuscular disease? , 2009, Respiratory medicine.
[56] D. de Benedictis,et al. Aspiration lung disease. , 2009, Pediatric clinics of North America.
[57] A. Clément,et al. Carbon dioxide monitoring during long-term noninvasive respiratory support in children , 2009, Intensive Care Medicine.
[58] P. Beuret,et al. Interest of an objective evaluation of cough during weaning from mechanical ventilation , 2009, Intensive Care Medicine.
[59] A. Greenough,et al. Measurement of maximal inspiratory pressure in ventilated children , 2008, Pediatric pulmonology.
[60] Paola Baiardi,et al. Cough Peak Flows: Standard Values for Children and Adolescents , 2008, American journal of physical medicine & rehabilitation.
[61] T. Suga,et al. Mdx respiratory impairment following fibrosis of the diaphragm , 2008, Neuromuscular Disorders.
[62] N. Romero,et al. Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset , 2007, Annals of neurology.
[63] H. Granzier,et al. Structure–function relations of the giant elastic protein titin in striated and smooth muscle cells , 2007, Muscle & nerve.
[64] N. Laing. Congenital myopathies , 2007, Current opinion in neurology.
[65] C. Wallgren‐Pettersson,et al. Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy , 2007, Nature Genetics.
[66] P. Gay,et al. Current issues in home mechanical ventilation. , 2007, Chest.
[67] Ching H. Wang,et al. Consensus Statement for Standard of Care in Spinal Muscular Atrophy , 2007, Journal of child neurology.
[68] Janet Stocks,et al. An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. , 2007, American journal of respiratory and critical care medicine.
[69] J. Noyes. Health and quality of life of ventilator-dependent children. , 2006, Journal of advanced nursing.
[70] M. Antonelli,et al. Noninvasive Ventilation in Childhood Acute Neuromuscular Respiratory Failure: A Pilot Study , 2006, Respiration.
[71] M. Polkey,et al. Respiratory muscle testing: a valuable tool for children with neuromuscular disorders. , 2006, American journal of respiratory and critical care medicine.
[72] N. Romero,et al. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy. , 2006, Brain : a journal of neurology.
[73] T. Voit,et al. Predictors of severe chest infections in pediatric neuromuscular disorders , 2006, Neuromuscular Disorders.
[74] G. Grimby,et al. Diaphragmatic function in advanced Duchenne muscular dystrophy , 2006, Neuromuscular Disorders.
[75] David Gozal,et al. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. , 2004, American journal of respiratory and critical care medicine.
[76] T. Voit,et al. Respiratory function in congenital muscular dystrophy and limb girdle muscular dystrophy 2I , 2004, Neurology.
[77] A. Simonds,et al. 117th ENMC Workshop: Ventilatory Support in Congenital Neuromuscular Disorders — Congenital Myopathies, Congenital Muscular Dystrophies, Congenital Myotonic Dystrophy and SMA (II) 4–6 April 2003, Naarden, The Netherlands , 2004, Neuromuscular Disorders.
[78] M. Polkey,et al. Limitations of sniff nasal pressure in patients with severe neuromuscular weakness , 2003, Journal of neurology, neurosurgery, and psychiatry.
[79] Jacob E. Barkley,et al. Ventilatory dysfunction in mdx mice: Impact of tumor necrosis factor–alpha deletion , 2003, Muscle & nerve.
[80] G. Kanel,et al. Tracheobronchomalacia and tracheal hemorrhage in patients with Duchenne muscular dystrophy receiving long-term ventilation with uncuffed tracheostomies. , 2003, Chest.
[81] A. Simonds,et al. Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness , 2003, European Respiratory Journal.
[82] T. Voit,et al. Daytime predictors of sleep disordered breathing in children and adolescents with neuromuscular disorders , 2003, Neuromuscular Disorders.
[83] Hala G. Zahreddine,et al. The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[84] Wayne N Frankel,et al. The muscular dystrophy with myositis (mdm) mouse mutation disrupts a skeletal muscle-specific domain of titin. , 2002, Genomics.
[85] E. Hardeman,et al. A mutation in alpha-tropomyosin(slow) affects muscle strength, maturation and hypertrophy in a mouse model for nemaline myopathy. , 2001, Human molecular genetics.
[86] J. Bach,et al. Prevention of pulmonary morbidity for patients with neuromuscular disease. , 2000, Chest.
[87] C. Wallgren‐Pettersson,et al. MTM1 mutations in X‐linked myotubular myopathy , 2000, Human mutation.
[88] J. Mandel,et al. Identification of novel mutations in the MTM1 gene causing severe and mild forms of X‐linked myotubular myopathy , 1999, Human mutation.
[89] Wei Zhao,et al. Medical complications in long-term survivors with X-linked myotubular myopathy. , 1999, The Journal of pediatrics.
[90] M. Polkey,et al. Influence of acute lung volume change on contractile properties of human diaphragm. , 1998, Journal of applied physiology.
[91] J. Bach,et al. Criteria for extubation and tracheostomy tube removal for patients with ventilatory failure. A different approach to weaning. , 1996, Chest.
[92] A. Barois,et al. Thoracoabdominal pattern of breathing in neuromuscular disorders. , 1996, Chest.
[93] J. Marini,et al. Validation of a technique to assess maximal inspiratory pressure in poorly cooperative patients. , 1992, Chest.
[94] J. Bach,et al. LIFE SATISFACTION OF INDIVIDUALS WITH DUCHENNE MUSCULAR DYSTROPHY USING LONG-TERM MECHANICAL VENTILATORY SUPPORT , 1991, American journal of physical medicine & rehabilitation.
[95] M. Kaufman,et al. Pulmonary afferent control of breathing as end-expiratory lung volume decreases. , 1990, Journal of applied physiology.
[96] S. H. Wilson,et al. Predicted normal values for maximal respiratory pressures in caucasian adults and children. , 1984, Thorax.
[97] N. Romero,et al. Centronuclear myopathies. , 2013, Seminars in pediatric neurology.
[98] C. Wallgren‐Pettersson,et al. Orphanet Journal of Rare Diseases BioMed Central Review , 2008 .
[99] A. Clément,et al. Physiologic benefits of mechanical insufflation-exsufflation in children with neuromuscular diseases. , 2008, Chest.
[100] A. Beggs,et al. Mutations in dynamin 2 cause dominant centronuclear myopathy. , 2005, Nature genetics.
[101] C. Wallgren‐Pettersson. Congenital myopathies. , 2005, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[102] D. Annane,et al. Supine fall in lung volumes in the assessment of diaphragmatic weakness in neuromuscular disorders. , 2001, Archives of physical medicine and rehabilitation.
[103] J. Fitting,et al. Sniff nasal inspiratory pressure. Reference values in Caucasian children. , 1999, American journal of respiratory and critical care medicine.
[105] C. Gaultier,et al. Maximal static pressures in healthy children. , 1983, Respiration physiology.
[106] R. Griggs,et al. Evaluation of pulmonary function in neuromuscular disease. , 1981, Archives of neurology.